CareLit Fachartikel

Novel drug OTSSP167 inhibits proliferation and induces apoptosis selectively in high-grade serous ovarian cancer cells

R Kohler, H Kettelhack, A Schötzau, A Fedier, F Jacob, H Heinzelmann-Schwarz · Geburtshilfe und Frauenheilkunde · 2016 · Heft 10

Dokument
826527
CareLit-ID
Jahr
2016
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Geburtshilfe und Frauenheilkunde
Autor:innen
R Kohler, H Kettelhack, A Schötzau, A Fedier, F Jacob, H Heinzelmann-Schwarz
Ausgabe
Heft 10 / 2016
Seiten
–
Erschienen: 2016-10-13 00:00:00
ISSN
0016-5751

Zusammenfassung

Introduction: Our previous transcriptomic analysis identified MELK (maternal embryonic leucine-zipper kinase), suggested to play a key role in carcinogenesis, to be overexpressed in epithelial ovarian cancer. MELK is elevated and correlates with poor prognosis also in basal-like breast cancer and its inhibition by OTSSP167 induced apoptosis in these cells. We analyzed MELK expression in high-grade serous ovarian cancer (HGSOC) and determined the effect of MELK-inhibition in ovarian cancer cells and drug-resistant cells. Material and methods: Data base analysis was performed using public data sets via Gene Expres…

Schlagworte

Geburtshilfe und Frauenheilkunde